These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12639869)

  • 1. Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation.
    Cohen N; Almoznino-Sarafian D; Zaidenstein R; Alon I; Gorelik O; Shteinshnaider M; Chachashvily S; Averbukh Z; Golik A; Chen-Levy Z; Modai D
    Heart; 2003 Apr; 89(4):411-6. PubMed ID: 12639869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
    Oladapo OO; Falase AO
    Afr J Med Med Sci; 2000; 29(3-4):265-8. PubMed ID: 11714003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study.
    Eichhorn EJ; Tandon PK; DiBianco R; Timmis GC; Fenster PE; Shannon J; Packer M
    J Am Coll Cardiol; 1993 Mar; 21(3):634-40. PubMed ID: 8436744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure.
    Milionis HJ; Alexandrides GE; Liberopoulos EN; Bairaktari ET; Goudevenos J; Elisaf MS
    Eur J Heart Fail; 2002 Mar; 4(2):167-73. PubMed ID: 11959045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal dysfunction in congestive heart failure, pathophysiological and prognostic significance.
    Cohen N; Gorelik O; Almoznino-Sarafian D; Alon I; Tourovski Y; Weissgarten J; Chachashvily S; Shteinshnaider M; Modai D
    Clin Nephrol; 2004 Mar; 61(3):177-84. PubMed ID: 15077868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure.
    O'Keeffe S; Grimes H; Finn J; McMurrough P; Daly K
    Cardiology; 1992; 80(2):100-5. PubMed ID: 1611628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic action of pharmacological administration of magnesium in heart failure: a critical review of new data.
    Sueta CA; Patterson JH; Adams KF
    Magnes Res; 1995 Dec; 8(4):389-401. PubMed ID: 8861138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urinary magnesium during treatment of patients with chronic congestive heart failure.
    Oladapo OO; Falase AO
    Afr J Med Med Sci; 2000; 29(3-4):301-3. PubMed ID: 11714011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnesium in congestive heart failure].
    Ohtsuka S; Yamaguchi I
    Clin Calcium; 2005 Feb; 15(2):181-6. PubMed ID: 15692155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure.
    Cohen N; Alon I; Almoznino-Sarafian D; Zaidenstein R; Weissgarten J; Gorelik O; Berman S; Modai D; Golik A
    Clin Cardiol; 2000 Jun; 23(6):433-6. PubMed ID: 10875034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes in patients hospitalised with dysmagnesemia in the Northern Territory of Australia: a retrospective, longitudinal data-linkage study.
    Al-Maqbali JS; Al Alawi AM; Abeyaratne A; Majoni SW; Falhammar H
    Rural Remote Health; 2024 Jul; 24(3):8515. PubMed ID: 39075781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure.
    Gottlieb SS; Baruch L; Kukin ML; Bernstein JL; Fisher ML; Packer M
    J Am Coll Cardiol; 1990 Oct; 16(4):827-31. PubMed ID: 2212365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open comparative study of two diuretic combinations, frusemide/amiloride ('Frumil') and bumetanide/potassium chloride ('Burinex' K), in the treatment of congestive cardiac failure in hospital out-patients.
    Ramsay F; Crawford RJ; Allman S; Bailey R; Martin A
    Curr Med Res Opin; 1988; 10(10):682-9. PubMed ID: 3371084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triamterene may preserve lymphocyte magnesium and potassium in patients with congestive heart failure.
    Schwinger RH; Antoni DH
    Magnes Res; 1992 Mar; 5(1):29-32. PubMed ID: 1591140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrolyte disturbances and cardiac failure with hypomagnesaemia in anorexia nervosa.
    Fonseca V; Havard CW
    Br Med J (Clin Res Ed); 1985 Dec; 291(6510):1680-2. PubMed ID: 3935239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure in diabetes mellitus: clinical features and prognostic implications.
    Gorelik O; Almoznino-Sarafian D; Alon I; Shteinshnaider M; Chachashvily S; Tzur I; Modai D; Cohen N
    Cardiology; 2005; 103(3):161-6. PubMed ID: 15785022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular free magnesium in lymphocytes from patients with congestive cardiac failure treated with loop diuretics with and without amiloride.
    Ng LL; Garrido MC; Davies JE; Brochwicz-Lewinski MJ; Tan LB
    Br J Clin Pharmacol; 1992 Mar; 33(3):329-32. PubMed ID: 1576058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.